We next tested MUTZ5 and MHH-CALL-4 as two BCP-ALL cell lines that should be sensitive to this drug: both cell lines overexpress CRLF2 via an IGH@-CRLF2 translocation. Here, CHL1 is linked to acute lymphoblastic leukemia.